Market Access News | pharmaphorum

News

GBT claims EU approval for sickle cell drug Oxbryta

Global Blood Therapeutics' run of positive regulatory news for its oral sickle cell disease treatment Oxbryta has continued with an approval for the drug in Europe for patients aged over 12

News

AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Be...

AstraZeneca's Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus erythematosus (SLE) in the EU for more than 10 years.

News

Robert Califf confirmed as FDA commissioner in tight vote

It's official – President Joe Biden's choice for FDA commissioner, Robert Califf, has been confirmed to the role after a narrow 50 to 46 vote in the Senate that relied on crossover Republic

News

Lilly bags US okay for rival to GSK's COVID-19 drug Xevudy

Eli Lilly has been granted an emergency use authorisation from the FDA for bebtelovimab, its second COVID-19 antibody drug and a rival to GlaxoSmithKline and Vir Biotech's fast-growing Xevu

News

Eisai bites back against restricted coverage plan for Aduhel...

Japanese drugmaker Eisai has published comments filed with the US Centers for Medicare & Medicaid Services over its restrictive coverage proposal for beleaguered Alzheimer's drug Aduhel

News

Novo Nordisk gets NICE okay for obesity drug Wegovy

Novo Nordisk's new obesity therapy Wegovy has been recommended for routine NHS use by UK cost-effectiveness watchdog NICE, but in a narrower group of patients than is covered by its MHRA-ap

GBT claims EU approval for sickle cell drug Oxbryta

AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Be...

Robert Califf confirmed as FDA commissioner in tight vote

Lilly bags US okay for rival to GSK's COVID-19 drug Xevudy

Eisai bites back against restricted coverage plan for Aduhel...

Novo Nordisk gets NICE okay for obesity drug Wegovy

FDA starts review of Regeneron's drug for rare disease FOP

How to meet your physicians where they are online

News

Editor's Picks